Abstract:Importance: Despite posing a significant challenge to global tuberculosis (TB) elimination efforts, recurrent TB remains understudied due to the challenges of long-term observation. Objective: To investigate the burden of recurrent TB using data from patients with pulmonary TB (PTB) in China. Design, setting, and participants: This retrospective cohort study included all bacteriologically confirmed or clinically diagnosed PTB cases reported to the Tuberculosis Information Management System with completed or successful treatment outcomes from January 1, 2005, to December 31, 2021. Data were analyzed from July 15, 2022, to October 28, 2023. Exposures: Newly diagnosed PTB was classified into primary, hematogenous disseminated, or secondary PTB. Main outcomes and measures: The primary outcome was the annual recurrence rate, stratified by disease classification, over the 17-year observation period. The recurrence rate for year n was calculated by dividing the number of patients with recurrent TB in year n by observed person-years in year n. The secondary outcome was the annual proportion of recurrent TB among reported cases and associated risk factors. Results: Of 13 833 249 patients with TB reported to the Tuberculosis Information Management System, 10 482 271 with PTB met the inclusion criteria. Of these, 68.9% were male, 22.3% were 65 years or older, 89.6% were of Han ethnicity, and 68.4% were agricultural workers. A total of 413 936 patients experienced a recurrent TB episode after successful treatment, resulting in an overall recurrence rate of 0.47 (95% CI, 0.47-0.48) per 100 person-years. The recurrence rate for patients with primary PTB was 0.24 (95% CI, 0.22-0.26) per 100 person-years; for hematogenous disseminated PTB, 0.37 (95% CI, 0.36-0.38) per 100 person-years; and for secondary PTB, 0.48 (95% CI, 0.47-0.48) per 100 person-years. The cumulative proportion of recurrences within the first 2 years accounted for 48.9% of all recurrent cases. The proportion of recurrent cases among notified incident cases increased 1.9-fold from 4.7% in 2015 to 8.8% in 2021. Among other factors, ages 45 to 64 years (adjusted hazard ratio, 1.77 [95% CI, 1.65-1.89]) and having completed treatment (adjusted hazard ratio, 1.16 [95% CI, 1.14-1.18]) were identified as associated with recurrence. Conclusions and relevance: In this retrospective cohort study, the PTB recurrence rate was substantially higher than the incidence, and the proportion of recurrent cases increased. Almost half of the recurrence occurred within the first 2 years, suggesting that routine posttreatment follow-up may represent an important strategy for accelerating TB elimination.

Recurrent Tuberculosis and Exogenous Reinfection, Shanghai, China

Recurrent Tuberculosis in an Urban Area in China: Relapse or Exogenous Reinfection?

[Study on the Cause of Tuberculosis Recurrence by Mycobacterium Tuberculosis Genotyping Method].

Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China

Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing

Epidemiology of recurrent pulmonary tuberculosis by bacteriological features of 100 million residents in China

The analysis of causes that result in re-treatment of drug-resistant tuberculosis in Zhejiang

Investigation on the cause of recurrent tuberculosis in a rural area in China using whole-genome sequencing: A retrospective cohort study

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

[Multiple Infections of Mycobacterium Tuberculosis in Treated Patients].

Recurrent Pulmonary Tuberculosis in China, 2005 to 2021

Mixed Infections of Mycobacterium Tuberculosis in Tuberculosis Patients in Shanghai, China

[Recurrent tuberculosis: relapse or reinfection?]

Transmission of Drug-Resistant Tuberculosis among Treated Patients in Shanghai, China

[Study on the Molecular Epidemiology of Mycobacterium Tuberculosis in Shanghai].

Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China

Non-Beijing Strains of Mycobacterium Tuberculosis in China

A Whole-Genome Sequencing-Based Study to Delineate the Risk and Characteristics of Tuberculosis Transmission in an Insular Population Over 10 Years in Shanghai

Transmission of Multidrug-Resistant Mycobacterium Tuberculosis in Shanghai, China: a Retrospective Observational Study Using Whole-Genome Sequencing and Epidemiological Investigation.

A Population-Based Genomic Epidemiological Study of the Source of Tuberculosis Infections in an Emerging City: Shenzhen, China

Internal Migration and Transmission Dynamics of Tuberculosis in Shanghai, China: an Epidemiological, Spatial, Genomic Analysis.